Published • loading... • Updated
Aytu BioPharma (NASDAQ:AYTU) Releases Quarterly Earnings Results, Beats Estimates By $0.24 EPS
Summary by thecerbatgem.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Aytu BioPharma (NASDAQ:AYTU) Releases Quarterly Earnings Results, Beats Estimates By $0.24 EPS
Aytu BioPharma (NASDAQ:AYTU – Get Free Report) announced its earnings results on Tuesday. The company reported ($0.05) EPS for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.24, Zacks reports. Aytu BioPharma had a negative return on equity of 63.03% and a negative net margin of 24.76%.The firm had revenue of $16.11 million for […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
